Pacira Pharmaceuticals buy JPMorgan Chase & Co.
Start price
07.03.24
/
50%
€28.20
Target price
07.03.25
€41.38
Performance (%)
0.00%
Price
15.05.24
€27.40
Summary
This prediction is currently active. JPMorgan_Chase___Co_'s BUY prediction for Pacira Pharmaceuticals is currently unchanged. This prediction currently runs until 07.03.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | 15.702% | 15.702% |
iShares Core DAX® | 1.851% | 5.158% |
iShares Nasdaq 100 | 1.573% | 2.589% |
iShares Nikkei 225® | -0.412% | -2.857% |
iShares S&P 500 | 1.128% | 2.485% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $45.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat